Merck & Co., Inc. Expresses Confidence in the Efficacy and Safety Profiles of ZETIA(R) (ezetimibe) and VYTORIN(R) (ezetimibe/simvastatin) as Effective Medicines for Managing Elevated Cholesterol
ORLANDO, Fla.--(BUSINESS WIRE)--At the American Heart Association meeting today, Merck & Co., Inc. said it is confident in the safety and efficacy profiles of ZETIA® (ezetimibe) and VYTORIN® (ezetimibe/simvastatin), and issued the following comment in response to misinterpretation of results from a small 200-patient imaging study called ARBITER 6.